Manmohan Undergoes Surgical Operation At AIIMS

New Delhi: For benign enlargement of the prostate gland, Prime Minister Dr. Manmohan Singh today went through a surgical operation at the All India Institute of Medical Sciences (AIIMS).

Sanjaya Baru, Manmohan’s Media Adviser stated that the operation took place to treat benign prostatic dysplasia of the prostate gland.

“The Prime Minister was recovering and has had a stable post operative course,” Mr. Baru added.

For the next two days, Mr. Singh will stay at hospital, and it is likely that he will go back home by Monday morning.

Pratibha Gives Away 53rd National Film Awards

New Delhi: President Pratibha Patil gave away the 53rd National Film Awards for the year 2005, and also presented far-famed film producer Shyam Benegal with the Dadasaheb Phalke Award at the dazzling ceremonial occasion.

While lecturing at the function, Patil emphasized on the uniqueness of the films, adding up that country’s rich history, traditions and background presents a strong base for the novelty and uniqueness of the Indian cinema.

ZTE Looking For Indian Mate For R&D

Shenzhen (China): ZTE is making exploratory survey for Indian partners in order to start research and development in broadband and internet protocol TV (IPTV) products.

Two ASI Officials Suspended Over Ram Setu Controversy

New Delhi: Two functionaries of Archaeological Survey of India (ASI) have been suspended over Ram Setu affidavit controversy.

One of the suspended officials was the director administration whereas the other was of the grade of assistant director.

Both were accountable for the drafting of the affidavit with the divisive citations to Ram that resulted to a storm of protestations.

FDA Okays New Blood Typing Examinations

Washington: The U.S. Food and Drug Administration has approved 15 new blood typing examinations intended to perk up the safety of blood transfusion.

The tests that were previously unavailable in the US are called blood grouping reagents.

The FDA has stated that the tests find out the blood type of blood donors, a vital step in guaranteeing safe blood transfusion for patients. If incompatible blood is administered to a patient, it may cause a grave and possibly deadly reaction.

Satyam To Drive Europe-Asia Market Through Acquisitions

Mumbai: Satyam Computer Services Ltd is concentrating on mounting its earnings from European as well as Asian markets, and is looking at developing both geographically plus through acquirements. Rising verticals including energy and utilities, retail, media and entertainment and travel, transport & logistics will be its key growth drivers in the worldwide foray.

Pages

News in Focus

Vedanta Aluminium Metal Share Price Target at Rs 520: ICICI Securities

ICICI Securities has maintained a Buy rating on Vedanta Aluminium Metal, holding its target price at Rs 520, implying 14% upside from the current market price of Rs 457.

Bajaj Finance Share Price Target at Rs 1,300: Motilal Oswal

Motilal Oswal has upgraded its rating on Bajaj Finance to Buy from Neutral, setting a target price of Rs 1,300, implying 23% upside from the current market price of Rs 1,054.

Mahindra & Mahindra Share Price Target at Rs 4,100 as Plan Execution Remains Strong: ICICI Securities

ICICI Securities has maintained a Buy rating on Mahindra & Mahindra, raising its target price to Rs 4,100 from Rs 4,000, implying 25% upside from the current market price of Rs 3,284.

Home First Finance Share Price Target at Rs 1,400: IDBI Capital

IDBI Capital has reiterated a Buy rating on Home First Finance Company, setting a target price of Rs 1,400, implying 19% upside from the current market price of Rs 1,181.

Suzlon Energy Share Price Target at Rs 65: ICICI Direct

ICICI Securities has maintained a Buy rating on Suzlon Energy, retaining an unchanged target price of Rs 65, implying 35% upside from the current market price of Rs 48.

Tata Power Share Price Target at Rs 485: ICICI Securities

ICICI Securities has reiterated a Buy rating on Tata Power Company, maintaining a target price of Rs 485, implying 31% upside from the current market price of Rs 371.